Health-related quality of life impact of idelalisib in patients with relapsed chronic lymphocytic leukemia (CLL): Phase 3 results Meeting Abstract


Authors: Munir, T.; Hillmen, P.; Eradat, H.; Ghia, P.; O'Brien, S.; Furman, R.; Coutre, S.; Sharman, J.; Cheson, B.; Pagel, J.; Barrientos, J.; Zelenetz, A.; Kipps, T.; Flinn, I.; Lamanna, N.; Hallek, M.; Coiffier, B.; Pettitt, A.; Kim, Y.; Jahn, T.; Wagner, L.
Abstract Title: Health-related quality of life impact of idelalisib in patients with relapsed chronic lymphocytic leukemia (CLL): Phase 3 results
Meeting Title: 55th Annual Scientific Meeting of the British Society for Haematology
Journal Title: British Journal of Haematology
Volume: 169
Issue: Suppl. 1
Meeting Dates: 2015 Apr 20-22
Meeting Location: Edinburgh, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2015-04-01
Start Page: 53
Language: English
ACCESSION: WOS:000353231200125
PROVIDER: wos
PUBMED: 25891202
DOI: 10.1111/bjh.13350
Notes: Meeting Abstract: 124 -- 55th Annual Scientific Meeting of the British-Society-for-Haematology -- APR 20-22, 2015 -- Edinburgh, SCOTLAND -- SI -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nicole Lamanna
    60 Lamanna
  2. Andrew D Zelenetz
    767 Zelenetz